Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
START SYNERGY: ELV001 in Active Rheumatoid Arthritis
NCT07409103Phase 2Recruiting
- Sponsor
- Elevara Medicines
- Start
- Feb 2026
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of ELV001 in rheumatoid arthritis (RA), sponsored by Elevara Medicines. Started Feb 2026; status: recruiting.
02
Drugs
ELV001
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT07409103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07409103.